Publikace
- Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas2022 | 1. lékařská fakulta, 2. lékařská fakulta, Lékařská fakulta v Plzni, Fakulta tělesné výchovy a sportu
- Anti-CD38 Therapy with Daratumumab for Relapsed/Refractory CD20-Negative Diffuse Large B-Cell Lymphoma2020 | 1. lékařská fakulta, 2. lékařská fakulta
- Overcoming resistance to rituximab in relapsed non-Hodgkin lymphomas by antibody-polymer drug conjugates actively targeted by anti-CD38 daratumumab2020 | 1. lékařská fakulta
- Cotargeting of BCL2 with venetoclax and MCL1 with S63845 is synthetically lethal in vivo in relapsed mantle cell lymphoma2019 | 1. lékařská fakulta, 2. lékařská fakulta
- Single-agent cytarabine is insufficient for the treatment of human mantle cell lymphoma in mouse xenograft model2016 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové
- Significantly higher numbers of proB cells in healthy Caucasians compared to Asians: Is there association with incidence of CLL?2016 | 1. lékařská fakulta
- Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo2016 | 1. lékařská fakulta
- Trefoil factor family (TFF) proteins as potential serum biomarkers in patients with metastatic colorectal cancer2015 | 1. lékařská fakulta
- Detailed Functional and Proteomic Characterization of Fludarabine Resistance in Mantle Cell Lymphoma Cells2015 | 1. lékařská fakulta
- Mouse models of mantle cell lymphoma, complex changes in gene expression and phenotype of engrafted MCL cells: implications for preclinical research2014 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové
Loading network view...
